Granulocytes and CD19+ cells had higher MAFMRP1 in the RA-groups with the adjusted model, while the other leukocyte groups have higher MAFTotal and MAFMDR1 and lower MAFMRP1. This evidence concerns the gene CD19 and rheumatoid arthritis.